Literature DB >> 3915945

Classification of amyloidosis: immunohistochemistry versus the potassium permanganate method in differentiating AA from AL amyloidosis.

S Janssen, J D Elema, M H van Rijswijk, P C Limburg, S Meijer, E Mandema.   

Abstract

As systemic AA and Al amyloidosis differ considerably with regard to prognosis and therapeutic approach, it is of importance to make an accurate histochemical classification with regard to the amyloid protein involved. In the present study the results of the potassium permanganate (KMnO4) method, an indirect histochemical procedure based on differences in cross-beta-potential of different amyloid fibril proteins, were compared with the results of an immunohistochemical method utilizing anti-AA and anti-AP antibodies. Renal biopsy sections of patients with systemic amyloidosis related to inflammatory conditions, systemic amyloidosis associated with plasma cell dyscrasia, idiopathic systemic amyloidosis, and nonamyloidotic controls were studied. Positive reaction of anti-AA was observed on all KMnO4-sensitive amyloid deposits, whereas the KMnO4-resistant amyloid deposits remained unstained, provided that highly purified anti-AA antiserum was used. Anti-AP produced not only comparable staining of both KMnO4-sensitive and -resistant amyloid deposits, but also of glomerular basement membranes and elastin layers of blood vessels in amyloid and control biopsies. The intensity of anti-AP reactivity was comparable with the reaction of anti-AA on KMnO4-sensitive amyloid deposits. The present results confirm the specificity of the KMnO4 method, which is a simple method available to every laboratory, in differentiating between AA and AL amyloidosis. Furthermore, the results indicate that, at least in renal biopsy specimens, anti-AP may serve as a general marker for AA and AL amyloid deposition; this finding is in contrast to the results of a recently published report.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3915945

Source DB:  PubMed          Journal:  Appl Pathol        ISSN: 0252-1172


  7 in total

Review 1.  Diffuse mesenteric amyloidosis.

Authors:  V Mohan; J A Kemp; H E Lewine; M Rabin; M L Goldstein; F A Farraye
Journal:  Dig Dis Sci       Date:  1997-05       Impact factor: 3.199

2.  Immunohistochemical demonstration of vitronectin in association with elastin and amyloid deposits in human kidney.

Authors:  K Dahlbäck; H Löfberg; B Dahlbäck
Journal:  Histochemistry       Date:  1987

3.  Amyloid neuropathy: immunocytochemical localization of intra- and extracellular immunoglobulin light chains.

Authors:  C Sommer; J M Schröder
Journal:  Acta Neuropathol       Date:  1989       Impact factor: 17.088

4.  AA amyloidosis associated with systemic lupus erythematosus.

Authors:  E J ter Borg; S Janssen; M H van Rijswijk; J Bijzet; P E de Jong; J D Elema; C G Kallenberg
Journal:  Rheumatol Int       Date:  1988       Impact factor: 2.631

5.  A quantitative method for detecting deposits of amyloid A protein in aspirated fat tissue of patients with arthritis.

Authors:  B P Hazenberg; P C Limburg; J Bijzet; M H van Rijswijk
Journal:  Ann Rheum Dis       Date:  1999-02       Impact factor: 19.103

6.  Soft-tissue uptake of 99mTc-diphosphonate and 99mTc-pyrophosphate in amyloidosis.

Authors:  S Janssen; D A Piers; M H van Rijswijk; S Meijer; E Mandema
Journal:  Eur J Nucl Med       Date:  1990

7.  Skin involvement in primary systemic amyloidosis.

Authors:  Susheel Kumar; Rimi Som Sengupta; Nandita Kakkar; Aman Sharma; Surjit Singh; Subhash Varma
Journal:  Mediterr J Hematol Infect Dis       Date:  2013-01-02       Impact factor: 2.576

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.